Progress in Cancer Immunotherapy

Lieferzeit: Lieferbar innerhalb 14 Tagen

160,49 €

inkl. 7 % MwSt. zzgl. Versandkosten

Advances in Experimental Medicine and Biology 909

ISBN: 9401775532
ISBN 13: 9789401775533
Herausgeber: Shuren Zhang
Verlag: Springer Verlag GmbH
Umfang: xii, 283 S., 1 s/w Illustr., 14 farbige Illustr., 283 p. 15 illus., 14 illus. in color.
Erscheinungsdatum: 06.06.2016
Auflage: 1/2016
Produktform: Gebunden/Hardback
Einband: GEB

This book provides readers an extensive overview of recent progress in basic and clinical research on cancer immunotherapy. Thanks to rapid advances in molecular biology and immunology, it has become increasingly evident that cancer growth is influenced by host immune responses. With the success of a number of clinical trials, immunotherapy has become a promising treatment modality of cancer. This book covers five major topics, including monoclonal antibodies, biological response modifiers, cancer vaccines, adoptive cellular therapy and oncolytic viruses. It also examines the combination of different immune strategies as well as the combination of immunotherapy with other treatments to increase anti-tumor effects. Through the comprehensive discussion of the topic, the book sheds valuable new light on the treatment of tumors.

Artikelnummer: 9057066 Kategorie:

Beschreibung

Autorenporträt

Dr. Shuren Zhang is a professor and the director of Department of Immunology, Cancer Institute & Hospital,Chinese Academy of Medical Sciences & Peking Union Medical College. He is the vice chairman of the society of Cancer Biotherapy of Chinese Anti-Cancer Association. His research focuses on tumor immunology and cancer immunotherapy, and he has published more than 60 research articles in this field.

Das könnte Ihnen auch gefallen …